mTOR plays critical roles in pancreatic cancer stem cells through specific and stemness-related functions

作者：Matsubara Shyuichiro; Ding Qiang; Miyazaki Yumi; Kuwahata Taisaku; Tsukasa Koichiro; Takao Sonshin^*

来源：Scientific Reports, 2013, 3: 3230.

DOI：10.1038/srep03230

Pancreatic cancer is characterized by near-universal mutations in KRAS. The mammalian target of rapamycin (mTOR), which functions downstream of RAS, has divergent effects on stem cells. In the present study, we investigated the significance of the mTOR pathway in maintaining the properties of pancreatic cancer stem cells. The mTOR inhibitor, rapamycin, reduced the viability of CD133(+) pancreatic cancer cells and sphere formation which is an index of self-renewal of stem-like cells, indicating that the mTOR pathway functions to maintain cancer stem-like cells. Further, rapamycin had different effects on CD133(+) cells compared to cyclopamine which is an inhibitor of the Hedgehog pathway. Thus, the mTOR pathway has a distinct role although both pathways maintain pancreatic cancer stem cells. Therefore, mTOR might be a promising target to eliminate pancreatic cancer stem cells.

• 出版日期2013-11-15